CIC
BIIB icon

Chase Investment Counsel’s Biogen BIIB Stock Holding History

Chase Investment Counsel’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-14,362
Closed -$5.8M – 96
2015
Q2 		$5.8M Sell
14,362
-467
-3% -$187K 2.11% 18
2015
Q1 		$6.26M Sell
14,829
-753
-5% -$297K 2.2% 11
2014
Q4 		$5.29M Buy
15,582
+26
+0.2% +$8.41K 1.88% 19
2014
Q3 		$5.15M Sell
15,556
-260
-2% -$85.7K 1.85% 18
2014
Q2 		$4.99M Sell
15,816
-727
-4% -$219K 1.69% 27
2014
Q1 		$5.06M Sell
16,543
-3,685
-18% -$1.17M 1.72% 25
2013
Q4 		$5.66M Buy
+20,228
New +$5.23M 1.67% 29

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Chase Investment Counsel's BIIB Position: Q3 2015 in Review

Chase Investment Counsel sold out of Biogen (BIIB) in Q3 2015, closing a stake of 14,362 shares — an estimated $5.8M sold.

Chase Investment Counsel first reported a position in BIIB in Q4 2013 and held it in 7 quarters. The position peaked at $6.26M in Q1 2015. 923 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Chase Investment Counsel reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • Chase Investment Counsel sold 14,362 Biogen shares in Q3 2015, an estimated $5.8M.
  • Chase Investment Counsel first reported a position in Biogen in Q4 2013 and held it in 7 quarters.
  • Chase Investment Counsel's Biogen position peaked at $6.26M in Q1 2015.
  • 923 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Chase Investment Counsel's 13F filing for Q3 2015, filed 29 Oct 2015.